| Date | Stock | Signal | Target | Start Price | Best Price (1Y) | Accuracy | Current Price |
|---|---|---|---|---|---|---|---|
| May 28, 2026 |
Argen X SE - ADR
ARGX
|
BUY |
$1,255.00
Est. +50%
|
$838.49 | $911.88 |
Pending
|
$893.52
+6.6%
|
| May 28, 2026 |
Equillium Inc
EQ
|
BUY |
$5.00
Est. +90%
|
$2.63 | $3.43 |
Pending
|
$2.81
+6.8%
|
| May 06, 2026 |
Spyre Therapeutics Inc.
SYRE
|
BUY |
$107.00
Est. +51%
|
$71.01 | $84.43 |
Pending
|
$80.79
+13.8%
|
| Mar 10, 2026 |
Cullinan Therapeutics Inc
CGEM
|
BUY |
$28.00
Est. +85%
|
$15.11 | $16.72 |
Pending
|
$13.70
-9.3%
|
| Mar 09, 2026 |
Dianthus Therapeutics Inc
DNTH
|
BUY |
$120.00
Est. +49%
|
$80.60 | $96.50 |
Pending
|
$82.07
+1.8%
|
| Mar 06, 2026 |
Jade Biosciences, Inc.
JBIO
|
BUY |
$40.00
Est. +184%
|
$14.07 | $27.96 |
Pending
|
$15.34
+9.0%
|
| Mar 05, 2026 |
AnaptysBio Inc
ANAB
|
BUY |
$85.00
Est. +48%
|
$57.36 | $72.27 |
Pending
|
$56.07
-2.2%
|
| Mar 04, 2026 |
Ascendis Pharma A/S - ADR
ASND
|
BUY |
$332.00
Est. +38%
|
$241.38 | $250.74 |
Pending
|
$218.06
-9.7%
|
| Feb 26, 2026 |
Argen X SE - ADR
ARGX
|
BUY |
$1,227.00
Est. +59%
|
$769.98 | $911.88 |
Pending
|
$893.52
+16.0%
|
| Feb 12, 2026 |
Ascendis Pharma A/S - ADR
ASND
|
BUY |
$325.00
Est. +49%
|
$218.04 | $250.74 |
Pending
|
$218.06
+0.0%
|
| Jan 05, 2026 |
Crinetics Pharmaceuticals Inc
CRNX
|
BUY |
$75.00
Est. +48%
|
$50.57 | $57.99 |
Pending
|
$34.47
-31.8%
|
| Dec 11, 2025 |
Ascendis Pharma A/S - ADR
ASND
|
BUY |
$256.00
Est. +27%
|
$201.37 | $250.74 |
Precision Hit (±3%)
|
$218.06
+8.3%
|
| Dec 08, 2025 |
Kymera Therapeutics Inc
KYMR
|
BUY |
$114.00
Est. +22%
|
$93.76 | $103.00 |
Pending
|
$86.21
-8.1%
|
| Nov 05, 2025 |
Viridian Therapeutics Inc
VRDN
|
BUY |
$48.00
Est. +98%
|
$24.24 | $34.29 |
Pending
|
$16.35
-32.5%
|
| Sep 18, 2025 |
Argen X SE - ADR
ARGX
|
BUY |
$882.00
Est. +21%
|
$731.77 | $934.62 |
Target Met
|
$893.52
+22.1%
|
| May 05, 2025 |
Jade Biosciences, Inc.
JBIO
|
BUY |
$19.00
Est. +65%
|
$11.50 | $27.96 |
Target Met
|
$15.34
+33.4%
|
| Mar 24, 2025 |
Crinetics Pharmaceuticals Inc
CRNX
|
BUY |
$60.00
Est. +67%
|
$35.94 | $57.99 |
Miss
|
$34.47
-4.1%
|
| Nov 12, 2024 |
Viridian Therapeutics Inc
VRDN
|
BUY |
$41.00
Est. +259%
|
$11.41 | $29.00 |
Miss
|
$16.35
+43.3%
|
| Nov 12, 2024 |
Spyre Therapeutics Inc.
SYRE
|
BUY |
$71.00
Est. +100%
|
$35.52 | $40.26 |
Miss
|
$80.79
+127.4%
|
| Nov 12, 2024 |
RAPT Therapeutics Inc
RAPT
|
BUY |
$2.00
Est. +15%
|
$1.74 | $42.39 |
Target Met
|
$58.01
+3233.6%
|
| Nov 06, 2024 |
Aclaris Therapeutics Inc
ACRS
|
BUY |
$3.00
Est. +32%
|
$2.28 | $5.17 |
Target Met
|
$4.32
+89.5%
|
| Sep 10, 2024 |
Viridian Therapeutics Inc
VRDN
|
BUY |
$40.00
Est. +361%
|
$8.68 | $27.20 |
Miss
|
$16.35
+88.4%
|
| Jul 22, 2024 |
Morphic Holding Inc
MORF
|
BUY |
$57.00
Est. +1%
|
$56.52 | $57.00 |
Bullseye Hit (±1%)
|
$56.99
+0.8%
|
| Jun 24, 2024 |
Argen X SE - ADR
ARGX
|
BUY |
$500.00
Est. +14%
|
$436.79 | $678.21 |
Target Met
|
$893.52
+104.6%
|
| Jun 17, 2024 |
Celldex Therapeutics Inc.
CLDX
|
BUY |
$58.00
Est. +66%
|
$34.91 | $47.00 |
Miss
|
$31.27
-10.4%
|
| Jun 17, 2024 |
Third Harmonic Bio Inc
THRD
|
BUY |
$23.00
Est. +78%
|
$12.95 | $16.02 |
Miss
|
$5.38
-58.5%
|
| May 30, 2024 |
Ascendis Pharma A/S - ADR
ASND
|
BUY |
$200.00
Est. +46%
|
$137.45 | $181.50 |
Miss
|
$218.06
+58.6%
|
| May 13, 2024 |
Apogee Therapeutics Inc.
APGE
|
BUY |
$95.00
Est. +80%
|
$52.71 | $63.50 |
Miss
|
$88.33
+67.6%
|
| May 07, 2024 |
Pliant Therapeutics Inc
PLRX
|
BUY |
$32.00
Est. +130%
|
$13.91 | $16.07 |
Miss
|
$1.13
-91.9%
|